NR4A1 and breast cancer: Specht et al. compared three different scoring systems on the SST expression in bronchopulmonary neoplasms: the immunoreactive score (IRS) originally developed for the evaluation of estrogen and progesterone receptors in breast cancer, the Her2/neu score developed for the evaluation of HER expression in breast cancer and the hormone receptor score (H score).